Entering text into the input field will update the search result below

Aeterna Zentaris up 19% premarket on positive macimorelin data

  • Thinly traded nano cap Aeterna Zentaris (NASDAQ:AEZS) jumps 19% premarket on average volume on the heels of positive results from a 24-subject study, AEZS-130-P01, evaluating macimorelin as a growth hormone stimulation test in pediatric patients with child-onset growth hormone deficiency (CGHD).
  • Results showed a favorable safety and tolerability profile with pharmacokinetic/pharmacodynamic characteristics in line with adult studies.
  • A validation study, AEZS-130-P02, is next up.

Recommended For You

Related Stocks

SymbolLast Price% Chg
AEZS
--
AEZS:CA
--